Dova Pharmaceuticals   Report issue

For profit Phase 4
Founded: Durham NC United States (2016)
Status: Acquired by Swedish Orphan Biovitrum (2019) → now Advent International (2021)

Organization Overview

First Clinical Trial
2018
NCT03326843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Dova Pharmaceuticals

Active Ingredients

Drugs in Phase 4 Trials (1)

avatrombopag (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liver Diseases (Phase 2)

Purpura, Thrombocytopenic, Idiopathic (Phase 3)

Thrombocytopenia (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 1